How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences
WATCH or LISTEN below, thank you for supporting MedtechWOMEN Talks!
In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies.
In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders.
TL;DR – Key takeaways:
- Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively
- The integration of market insights from the beginning is crucial for successful medical device commercialization
- Collaborative efforts across various functions are vital to address the comprehensive demands of product development
Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical!
Please subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.
Thank you for listening to MedtechWOMEN Talks!
WATCH Now:
LISTEN Now:
